-
BMS 309403: FABP4 Inhibitor Workflows
2026-09-01
Use BMS 309403 to connect FABP4 activity with macrophage lipid handling, inflammatory signaling, and foam cell formation. This practical guide covers cell-based assay design, atherosclerosis and metabolic disease applications, dosing logic, and troubleshooting for reproducible results.
-
Plk1 Control of p31comet in Checkpoint Disassembly
2026-09-01
The reference study identifies Polo-like kinase 1 (Plk1) as a direct negative regulator of p31comet-mediated mitotic checkpoint complex disassembly. By combining HeLa cell extracts, purified proteins, phosphorylation analysis, and an S102A mutant, the authors show how Plk1 phosphorylation can prevent premature checkpoint silencing during mitosis.
-
Sulfaphenazole: A Decision Framework for CYP2C9
2026-08-31
Sulfaphenazole is more than a CYP2C9 inhibitor: it is a useful bridge between enzyme selectivity, antimycobacterial screening, and vascular biology. This evidence-based guide explains how to choose assays, interpret concentrations, and avoid overextending translational conclusions.
-
Lanabecestat (AZD3293) in Reliable Cell Assays
2026-08-31
This scenario-driven guide explains how Lanabecestat (AZD3293), SKU BA8438, can be integrated into cell-based Alzheimer’s disease research while separating BACE1 pathway effects from nonspecific assay artifacts. It connects product specifications with published evidence on amyloid-beta reduction, synaptic transmission, dosing, and practical vendor selection.
-
PPARγ Activation in DSS-Induced IBD
2026-08-30
The reference study identifies PPARγ activation as a regulator of macrophage polarization in dextran sulfate sodium-induced inflammatory bowel disease, linking reduced STAT-1 signaling and enhanced STAT-6 signaling to improved intestinal inflammation and barrier integrity. Its combined cell and mouse experiments provide a mechanistic framework for evaluating PPARγ agonists in inflammatory process modulation while highlighting important limits of acute, preclinical models.
-
Polymyxin B: Designing Cleaner Immune Assays
2026-08-29
Polymyxin B sulfate is more than a membrane-active antibiotic in Gram-negative infection research. This guide explains how to separate direct bactericidal effects from dendritic-cell, inflammatory, and microbiome-related readouts when designing translational assays.
-
Vincristine Sulfate: Cancer Research Workflow
2026-08-28
Build more reproducible vincristine experiments by linking microtubule dynamics to dose–response design, orthogonal phenotyping, and recovery testing. This workflow distinguishes biochemical potency from cell-specific response and shows how to troubleshoot solubility, timing, and assay variability.
-
Dimetridazole Targets P. aeruginosa Quorum Sensing
2026-08-28
Yuan et al. show that Dimetridazole and Ribavirin can suppress Pseudomonas aeruginosa virulence-associated traits by perturbing quorum sensing regulation rather than acting solely as conventional growth inhibitors. The study connects phenotypic assays, transcriptomics, antibiotic-combination testing, and in vivo infection models to support an antivirulence research framework.
-
Niclosamide Workflows for Cancer Research
2026-08-27
Build more informative STAT3-centered cancer assays with Niclosamide by separating pathway suppression, proliferative arrest, and cell death. This workflow pairs mechanistic biomarkers with time-resolved viability measurements for prostate cancer and acute myelogenous leukemia model applications.
-
Metronidazole Workflows for OAT3 and Microbiome Studies
2026-08-27
Metronidazole is a versatile research probe for OAT3-mediated transport, drug-drug interaction modulation, and anaerobic microbiome experiments. This practical guide connects transporter assays with allergic-rhinitis microbiota workflows while clearly separating established evidence from protocol recommendations.
-
Captopril Workflows for ACE Inhibition Research
2026-08-26
Captopril supports a versatile workflow that spans quantitative ACE inhibition in hypertension research, bradykinin-linked intestinal physiology, and exploratory apoptosis induction in cancer cells. This guide translates its biochemical profile into practical assay design, cross-domain controls, solution-handling safeguards, and troubleshooting decisions.
-
Hexetidine (NSC-17764) Assay Workflows
2026-08-26
Build more informative oral antimicrobial studies with Hexetidine (NSC-17764), from strain-specific MIC testing to matrix-aware biofilm experiments. This workflow emphasizes solvent controls, saliva and protein effects, time-course endpoints, and copper-ion combination testing rather than relying on MIC alone.
-
Diphenyleneiodonium chloride in Redox Assays
2026-08-25
Diphenyleneiodonium chloride, or DPI, enables parallel interrogation of redox enzymes and GPR3-linked cAMP signaling. This guide translates a recent citrus canker resistance study into practical ROS, iron, viability, and pathway-control workflows while emphasizing DPI’s selectivity limits and troubleshooting requirements.
-
Leucovorin Calcium in Gastric Assembloids
2026-08-25
Leucovorin Calcium adds a controlled folate-rescue arm to patient-derived gastric assembloid experiments, helping separate tumor-intrinsic methotrexate sensitivity from stromal protection. This workflow combines matched organoids, stromal subpopulations, viability testing, and rescue-index analysis for more informative antifolate drug resistance research.
-
Doxycycline as a Mechanistic Probe in Cancer Models
2026-08-24
Doxycycline is more than a tetracycline antibiotic: it can help dissect metalloproteinase inhibition, matrix remodeling, and antiproliferative activity in cancer research. This guide shows how to distinguish direct compound effects from delivery-system, antimicrobial, and assay-specific confounders.